Cargando…
Comparison of the Safety and Pharmacokinetics of ST-246® after IV Infusion or Oral Administration in Mice, Rabbits and Monkeys
BACKGROUND: ST-246® is an antiviral, orally bioavailable small molecule in clinical development for treatment of orthopoxvirus infections. An intravenous (IV) formulation may be required for some hospitalized patients who are unable to take oral medication. An IV formulation has been evaluated in th...
Autores principales: | Chen, Yali, Amantana, Adams, Tyavanagimatt, Shanthakumar R., Zima, Daniela, Yan, X. Steven, Kasi, Gopi, Weeks, Morgan, Stone, Melialani A., Weimers, William C., Samuel, Peter, Tan, Ying, Jones, Kevin F., Lee, Daniel R., Kickner, Shirley S., Saville, Bradley M., Lauzon, Martin, McIntyre, Alan, Honeychurch, Kady M., Jordan, Robert, Hruby, Dennis E., Leeds, Janet M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156126/ https://www.ncbi.nlm.nih.gov/pubmed/21858040 http://dx.doi.org/10.1371/journal.pone.0023237 |
Ejemplares similares
-
Development of ST-246® for Treatment of Poxvirus Infections
por: Jordan, Robert, et al.
Publicado: (2010) -
Pharmacokinetics and Interspecies Allometric Scaling of ST-246, an Oral Antiviral Therapeutic for Treatment of Orthopoxvirus Infection
por: Amantana, Adams, et al.
Publicado: (2013) -
Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination
por: Grosenbach, Douglas W., et al.
Publicado: (2008) -
Mutational analysis of the potential catalytic residues of the VV G1L metalloproteinase
por: Honeychurch, Kady M, et al.
Publicado: (2006) -
Vaccinia virus p37 interacts with host proteins associated with LE-derived transport vesicle biogenesis
por: Chen, Yali, et al.
Publicado: (2009)